| Added by | mollevi |
|---|---|
| Group name | EquipeCG |
| Item Type | Note |
| Note | The following values have no corresponding Zotero field: auth-address: Inserm U955 Hopital Henri Mondor, Team 7 Translational Research of Genito-Urinary Oncogenesis, Creteil, France; Department of Medical Oncology, Hopital Saint-Louis, AP-HP, Paris, France. Electronic address: damien.pouessel@aphp.fr. CEpiA (Clinical Epidemiology and Ageing), Unit EA 4393, Paris Est University, Creteil, France; Public Health Department, Hopital Henri-Mondor, AP-HP, Creteil, France. Department of Medical Oncology, Institut Bergonie, Bordeaux, France. Department of Urology, Hopital Henri Mondor, AP-HP, Creteil, France. Department of Cancer Medicine and INSERM U981, Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. Departement d'Oncologie Medicale, Institut Claudius Regaud, IUCT-O, Toulouse, France. Department of Medical Oncology, Centre Francois Baclesse, Caen, France. Oncological Medicine, Institut Curie, Paris, France. Inserm U955 Hopital Henri Mondor, Team 7 Translational Research of Genito-Urinary Oncogenesis, Creteil, France; Department of Urology, Hopital Henri Mondor, AP-HP, Creteil, France; Paris Est University, Creteil, France. Inserm U955 Hopital Henri Mondor, Team 7 Translational Research of Genito-Urinary Oncogenesis, Creteil, France; Paris Est University, Creteil, France; Department of Pathology and Tissue Biobank Unit, Hopital Henri Mondor, AP-HP, Creteil, France. Department of Medical Oncology, Hopital Saint-Louis, AP-HP, Paris, France; Paris Diderot University, Paris, France. alt-title: Clinical genitourinary cancer accession-num: 27554584 |
| Tags | _EndnoteXML import |
| Date Added | 2018/07/20 - 10:05:58 |
| Date Modified | 2018/07/20 - 10:05:58 |
| Parent item | Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort |
Institut de Recherche en Cancérologie de
